The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
High-throughput mutation analysis in acute myeloid leukemia (AML).
J. Dunlap
No relevant relationships to disclose
C. L. Corless
No relevant relationships to disclose
W. H. Fleming
No relevant relationships to disclose
R. Braziel
No relevant relationships to disclose
N. Leeborg
No relevant relationships to disclose
K. Gatter
No relevant relationships to disclose
M. Loriaux
No relevant relationships to disclose
K. Kelemen
No relevant relationships to disclose
T. Kovacsovics
No relevant relationships to disclose
G. Fan
No relevant relationships to disclose